Company Profile

Sourcing Inquiry Logo Lonza

Lonza

Regions
Worldwide
Countries
Switzerland, Australia, …
Countries
Switzerland, Australia, Belgium, Brazil, China, Czech Republic, Denmark, France, Germany, Hungary, India, Italy, Japan, Netherlands, Poland, Russia, Singapore, Spain, United Kingdom, United States
Size
1000+
Specialty
Human Medicines, Biopharmaceuticals, …
Specialty
Human Medicines, Biopharmaceuticals, Cosmeceuticals, Nutraceuticals
Service category
Contract manufacturing, filling and packaging, Pharmaceutical process development and validation, …
Service category
Contract manufacturing, filling and packaging, Pharmaceutical process development and validation, Quality management services, Analytical laboratory and testing services
Content posted and uploaded by users. Want to add your company?
Your company? Get access to this profile.

Result

Average value of all company ratings [2]

Criteria

  • Expertise / Capability 4.0
  • Price-Performance Ratio 3.0
  • Confidentiality ---
  • Timeliness 3.0
  • Flexibility 3.0
  • Quality of work 3.5
  • Project contacts and care 3.0
  • Geographic proximity 4.5
  • Culture fit 3.0
  • Environmental sustainability 3.0
  • Financial stability ---
  • Contract / invoice performance 3.0

Single ratings

"No constant project contact for us"

Projects

Small scale recombinant monoclonal AB

Pro and contra

  • Phase I/II scale project went very well, not a difficult thing. All services in-house.

  • Company lost some key people during our project and no constant project contact for us.

average

Criteria

Expertise / Capability
4.0
Price-Performance Ratio
3.0
Confidentiality
---
Timeliness
3.0
Flexibility
3.0
Quality of work
3.0
View all »

[Verified Buyer from United States]

"They know what specific agencies expect such as MHRA for an IMP"

Projects

Clinical supply manufacture recombinant protein

Pro and contra

  • Due to the well established manufacture we could rely on their experience. They know what specific agencies expect such as MHRA for an IMP.

  • A discussion on a particle specification for a single batch IMP did not deliver pragmatic solutions in the first instance.

average

Criteria

Expertise / Capability
4.0
Price-Performance Ratio
3.0
Confidentiality
---
Timeliness
3.0
Flexibility
3.0
Quality of work
4.0
View all »

[Verified Buyer from Switzerland]

You might be also interested in

Sourcing this company's services?

Send inquiry anonymously »

Or add this Company to
Sourcing cart